Assessment of Epidermal Growth Factor Receptor (EGFR) expression in human meningioma

Radiation Oncology

Volumn 5, Issue 1, 2010, Pages

  Wernicke, A Gabriella ^a   Dicker, Adam P ^b   Whiton, Michal ^b   Ivanidze, Jana ^c   Hyslop, Terry ^b   Hammond, Elizabeth H ^d   Perry, Arie ^e   Andrews, David W ^b   Kenyon, Lawrence ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; EGFR PROTEIN, HUMAN;

ARTICLE; BENIGN TUMOR; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; MENINGIOMA; PROTEIN EXPRESSION; PROTEIN TARGETING; WORLD HEALTH ORGANIZATION; CANCER STAGING; ENZYME IMMUNOASSAY; METABOLISM; PATHOLOGY; PROGNOSIS; TISSUE MICROARRAY;

HUMANS; IMMUNOENZYME TECHNIQUES; MENINGEAL NEOPLASMS; MENINGIOMA; NEOPLASM STAGING; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TISSUE ARRAY ANALYSIS;

EID: 77952687041     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-5-46     Document Type: Article

References (47)

1. Rachlin JR, Rosenblum ML. Etiology and biology of meningiomas. 1991, New York: Raven Press.
2. DeMonte F. Current management of meningiomas. Oncology 2001, 9:83-96.
3. Jaaskelainen J, Haltia M, Servo A. Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome. Surg Neurol 1986, 25(3):233-242. 10.1016/0090-3019(86)90233-8, 3945904.
4. Mirimanoff RO, Dosoretz DE, Linggood RM, Ojemann RG, Martuza RL. Meningioma: analysis of recurrence and progression following neurosurgical resection. J Neurosurg 1985, 62(1):18-24. 10.3171/jns.1985.62.1.0018, 3964853.
5. Jaaskelainen J, Haltia M, Servo A. Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome. Surg Neurol 1986, 25(3):233-242. 10.1016/0090-3019(86)90233-8, 3945904.
6. Barbaro NM, Gutin PH, Wilson CB, Sheline GE, Boldrey EB, Wara WM. Radiation therapy in the treatment of partially resected meningiomas. Neurosurgery 1987, 20(4):525-528. 10.1227/00006123-198704000-00003, 3587542.
7. Goldsmith BJ, Wara WM, Wilson CB, Larson DA. Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990. J Neurosurg 1994, 80(2):195-201. 10.3171/jns.1994.80.2.0195, 8283256.
8. Taylor BW, Marcus RB, Friedman WA, Ballinger WE, Million RR. The meningioma controversy: postoperative radiation therapy. Int J Radiat Oncol Biol Phys 1988, 15(2):299-304.
9. Ennis BW, Lippman ME, Dickson RB. The EGF receptor system as a target for antitumor therapy. Cancer Invest 1991, 9:553-562. 10.3109/07357909109018953, 1933488.
10. Bucci B, D'Agnano I, Botti C, Mottolese M, Carico E, Zupi G, Vecchione A. EGF-R expression in ductal breast cancer: Proliferation and prognostic implications. Anticancer Res 1997, 17:769-774.
11. Salomon DS, Brandt R, Ciardiello F, Normanno N. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 1995, 19:183-232. 10.1016/1040-8428(94)00144-I, 7612182.
12. Ruben Grandis J, Melhem MF, Barnes EL, Tweardy DJ. Quantitative immunohistochemical analysis of transfroming growth factor alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck. Cancer 1996, 78:1284-1292. 10.1002/(SICI)1097-0142(19960915)78:6<1284::AID-CNCR17>3.0.CO;2-X, 8826952.
13. Rieske P, Kordek R, Bartkowiak J, Debiec-Rychter M, Biernat W, Liberski PP. A comparative study of epidermal growth factor receptor (EGFR) and MDM2 gene amplification and protein immunoreactivity in human glioblastomas. Pol J Pathol 1998, 49:145-149.
14. Goike HM, Asplund AC, Pettersson EH, Liu L, Sanoudou D, Collins VP. Acquired rearrangement of an amplified epidermal growth factor receptor (EGFR) gene in human glioblastoma xenograft. J Neuropathol Exp Neurol 1999, 58:697-701. 10.1097/00005072-199907000-00003, 10411339.
15. Messa C, Russo F, Caruso MG, Di Leo A. EGFR, TGF-alpha, and EGF-R in human colorectal adenocarcinoma. Acta Oncol 1998, 37:285-289. 10.1080/028418698429595, 9677101.
16. Libermann TA, Razon N, Bartal AD, Yarden Y, Schlessinger J, Soreq H. Expression of epidermal growth factor receptors in human brain tumors. Cancer Res 1984, 44:753-760.
17. Westermark B, Magnusson A, Heldin CH. Effects of epidermal growth factor on membrane motility and cell locomotion in cultures of human clonal glioma cells. J Neurosci Res 1982, 8:491-507. 10.1002/jnr.490080236, 6296418.
18. Weisman AS, Villemure JG, Kelly PA. Characterization of epidermal growth factor receptor in human meningioma. Cancer Res 1987, 47:2172-2176.
19. Kleihues P, Cavenee WK. Pathology and genetics, tumours of the nervous system. International Agency for Research on Cancer. Lyon, France 2000, 176-184.
20. Louis DN, Ohgaki H, Weistler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P. WHO Classification of Tumours of the Central Nervous System. 2007, Geneva: WHO Press, 3.
21. Andersson U, Guo D, Malmer B, Bergenheim AT, Brännström T, Hedman H, Henriksson R. Epidermal growth factor receptor family (EGFR, ErbB2-4) in gliomas and meningiomas. Acta Neuropathol 2004, 108(2):135-142. 10.1007/s00401-004-0875-6, 15148612.
22. Bianco R, Damiano V, Gelardi T, Ciardiello F, Tortora G. Rational combination of targeted therapies as a strategy to overcome the mechanisms of resistance to inhibitors of EGFR signaling. Curr Pharm 2007, 13(33):3358-3367.
23. Lee J, Chu E. First-line use of anti-epidermal growth factor receptor monoclonal antibodies in metastatic colorectal cancer. Clin Colorectal Cancer 2007, 6(Suppl 2):S42-46. 10.3816/CCC.2007.s.001, 18021486.
24. Astsaturov I, Cohen RB, Harari P. EGFR-targeting monoclonal antibodies in head and neck cancer. Curr Cancer Drug Targets 2007, 7(7):650-665. 10.2174/156800907782418365, 18045070.
25. Blick SK, Scott LJ. Cetuximab: a review of its use in squamous cell carcinoma of the head and neck and metastatic colorectal cancer. Drugs 2007, 67(17):2585-2607. 10.2165/00003495-200767170-00008, 18034592.
26. Gridelli C, Rossi A, Maione P, Colantuoni G, Del Gaizo F, Ferrara C, Nicolella D, Guerriero C. Erlotinib in no-small-cell lung cancer. Expert Opin Pharmacother 2007, 8(15):2579-2592. 10.1517/14656566.8.15.2579, 17931092.
27. Thatcjer N. The place of targeted therapy in the patient management of non-small cell lung cancer. Lung Cancer 2007, 57(Suppl 2):S18-23. 10.1016/S0169-5002(07)70423-3, 17686441.
28. Piccart-gebhart MJ, Procter M, Leyland-Jones B, Goldhirsch A, Untch M, Smith I, Gianni L, Baselga J, Bell R, Jackisch C, Cameron D, Dowsett M, Barrios CH, Steger G, Huang CS, Andersson M, Inbar M, Lichinitser M, Láng I, Nitz U, Iwata H, Thomssen C, Lohrisch C, Suter TM, Rüschoff J, Suto T, Greatorex V, Ward C, Straehle C, McFadden E, Dolci MS, Gelber RD. Trastuzumab after adjuvant chemotherapy in Her2-positive breast cancer. N Engl J Med 2005, 353(16):1659-1672. 10.1056/NEJMoa052306, 16236737.
29. Sanfilippo JS, Rao CV, Guarnascelli JJ. Detection of epidermal growth factor and transforming growth factor alpha protein in meningiomas and other tumors of central nervous system in human beings. Surg Gynecol Obstet 1993, 177:488-496.
30. Westphal M, Herrmann HD. Epidermal growth factor receptors on cultured human meningioma cells. Acta Neurochir 1986, 83:62-66.
31. Weisman AS, Villemure JG, Kelly PA. Regulation of DNA synthesis and growth of cells derived from primary human meningiomas. Cancer Res 1986, 46:2545-2550.
32. Maurizi M, Almadori G, Ferrandina G. Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma. Br J Cancer 1996, 74:1253-1257. 2075924, 8883413.
33. Carroll RS, Black PM, Zhang J, Kirsch M, Percec I, Lau N, Guha A. Expression and activation of epidermal growth factor receptors in meningiomas. J Neurosurg 1997, 87(2):315-323. 10.3171/jns.1997.87.2.0315, 9254099.
34. Diedrich U, Lucius J, Baron E, Behnke J, Pabst B, Zoll B. Distribution of epidermal growth factor receptor gene amplification in brain tumours and correlation to prognosis. J Neurol 1995, 242(10):683-688. 10.1007/BF00866920, 8568531.
35. DiCarlo A, Mariano A, Macchia PE, Moroni MC, Beguinot L, Macchia V. Epidermal growth factor receptor in human brain tumors. J Endocrinol Invest 1992, 15(1):31-37.
36. Johnson MD, Horiba M, Winnier AR, Artiaga CL. The epidermal growth factor receptor is associated with phospholipase C-gamma 1 in meningiomas. Hum Pathol 1994, 25(2):146-153. 10.1016/0046-8177(94)90270-4, 8119714.
37. Jones NR, Rossi ML, Gregoriou M, Hughes JT. Epidermal Growth Factor Receptor expression in 72 meningiomas. Cancer 1990, 66(1):152-155. 10.1002/1097-0142(19900701)66:1<152::AID-CNCR2820660127>3.0.CO;2-5, 2354402.
38. Dorward NL, Hawkins RA, Whittle IR. Epidermal growth factor receptor activity and clinical outcome in glioblastoma and meningioma. Br J Neurosurg 1993, 7(2):197-199. 10.3109/02688699309103479, 8388222.
39. Shiurba RA, Eng LF, Vogel H, Lee YL, Horoupian DS, Urich H. Epidermal growth factor receptor in meningiomas is expressed predominantly on endothelial cell. Cancer 1988, 62(10):2139-2144. 10.1002/1097-0142(19881115)62:10<2139::AID-CNCR2820621013>3.0.CO;2-G, 3052782.
40. Camby I, Nagy N, Rombaut K, Gras T, Duponchelle C, Pasteels JL, Brotchi J, Kiss R, Salmon I. Influence of epidermal growth factor and gastrin on the cell proliferation of human meningiomas versus astrocytic tumors maintained as ex vivo tissue cultures. Neuropeptides 1997, 31(3):217-225. 10.1016/S0143-4179(97)90051-2, 9243517.
41. Kong YG, Su CB, Ren ZY, Wang RZ. Measurement of epidermal growth factor receptor concentration in the pre-and post-operative serum in patients with meningiomas. Zhongguo Yi Xue Ke Yuan Xue Bao 2002, 24(4):427-429.
42. Lusis EA, Chicoine MR, Perry A. A high throughput screening of meningioma biomarkers using a tissue microarray. J Neurooncol 2005, 73:219-223. 10.1007/s11060-004-5233-y, 15980972.
43. Smith JS, Lal A, Harmon-Smith M, Bollen AW, McDermott MW. Association between absence of epidermal growth factor receptor immunoreactivity and poor prognosis in patients with atypical meningioma. J Neurosurg 2007, 106:1034-1040. 10.3171/jns.2007.106.6.1034, 17564176.
44. Ang KK, Berkley BA, Tu X. Impact of Epidermal Growth Factor Receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res 2002, 62:7350-7356.
45. Bonner JA, Giralt J, Harari PM. Cetuximab prolongs survival in patients with locoregionally advanced head and neck cancer: A phase III study of high dose radiation therapy with and without cetuximab. J Clin Oncology, 2004 ASCO Annual Meeting Proceedings (Post-Meeting Edition) 22(14S):5507.
46. Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, Ove R, Kies MS, Baselga J, Youssoufian H, Amellal N, Rowinsky EK, Ang KK. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006, 9; 354(6):567-78.
47. Zhu A, Shaeffer J, Leslie S. Epidermal growth factor receptor: An independent predictor of survival in astrocytic tumors given definitive irradiation. Int J Radiation Oncology Biol Phys 1996, 34:809-815.